BOOK-CHAPTER

In Silico Drug Repositioning for COVID-19: Progress and Challenges

Keywords:
Drug repositioning Repurposing Coronavirus disease 2019 (COVID-19) Drug Timeline Drug development Pandemic Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2019-20 coronavirus outbreak Medicine Intensive care medicine Pharmacology Virology Biology Geography Internal medicine Infectious disease (medical specialty)

Metrics

1
Cited By
1.69
FWCI (Field Weighted Citation Impact)
67
Refs
0.79
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Antifungal resistance and susceptibility
Health Sciences →  Medicine →  Infectious Diseases
Colorectal Cancer Treatments and Studies
Health Sciences →  Medicine →  Oncology
SARS-CoV-2 and COVID-19 Research
Health Sciences →  Medicine →  Infectious Diseases

Related Documents

JOURNAL ARTICLE

Computational Drug Repositioning: Current Progress and Challenges

Younhee Ko

Journal:   Applied Sciences Year: 2020 Vol: 10 (15)Pages: 5076-5076
JOURNAL ARTICLE

In silico approaches to drug repositioning for COVID-19 at AMED-BINDS

Takatsugu HirokawaMasakazu SekijimaShigenori TanakaHaruki Nakamura

Journal:   Proceedings for Annual Meeting of The Japanese Pharmacological Society Year: 2020 Vol: 93 (0)Pages: 2-ES
JOURNAL ARTICLE

AI3SD Video: Drug Repositioning for COVID-19

John P. Overington

Journal:   ePrints Soton (University of Southampton) Year: 2020
JOURNAL ARTICLE

COVID-19: Analysis of Drug Repositioning Practice

П.И. СавосинаДмитрий Сергеевич ДружиловскийVladimir Poroikov

Journal:   Pharmaceutical Chemistry Journal Year: 2021 Vol: 54 (10)Pages: 989-996
© 2026 ScienceGate Book Chapters — All rights reserved.